← Back to screener

Omada Health, Inc. OMDA

Rank #2023 · Nasdaq · $1.1B market cap
Audited by Deloitte & Touche LLP, no going-concern flag in the latest filing.
Score
36.0
P/E
-16.5
P/B
-3.80
ROE
23.0%
Op. Margin
-53.8%
Debt Ratio
-29%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★☆☆☆☆
Poor

P/E -16.5x, P/B -3.80x. Ranks in the top 91% of the universe.

Profitability ★★☆☆☆
Average

ROE 23.0%. Ranks in the top 53% of the universe.

Safety ★★★★★
Excellent

Debt ratio -29%. Ranks in the top 7% of the universe. Under 100% is generally considered a safe level.

Growth –
No data

Not enough historical filings to compute year-over-year growth yet.

Safety is the relative strength · Valuation is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2025$0.1B$-0.1B$-0.1B$-0.3B-53.8-29

← See the full screener